VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2019 | Future treatment options for squamous cell lung cancer

Paul Paik • 3 Jun 2019
ASCO 2019
Lung Cancer

Speaking from the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL, Paul Paik of the Memorial Sloan Kettering Cancer Center, New York, NY discusses future direction for squamous cell lung cancer treatment and the potential for immunotherapy.

More from Paul Paik

2:48
VISION trial: subset efficacy analyses of tepotinib for NSCLC
Paul Paik • 26 Jan 2021
0:48
Patient impact: development of drugs to treat METex14 alterations
Paul Paik • 3 Jun 2019
0:55
Squamous cell lung cancer: gene targets
Paul Paik • 3 Jun 2019
1:04
Tepotinib: advanced non-small cell lung cancer
Paul Paik

Related Videos

3:58
BrainStorm: improving prediction, diagnosis and management of brain metastases
Ahmad Awada • 6 May 2021
3:38
Impact of COVID-19 on lung cancer diagnosis and outcomes in the UK
David Baldwin • 29 Apr 2021
6:04
Cellular therapy in solid tumors
Andrew Furness • 27 Apr 2021
14:20
Cellular therapy in NSCLC
Andrew Furness • 27 Apr 2021
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals